Thane Wettig
CEO, Director · KYNTRA BIO, INC.
IndividualBuying only
- 2024
- Sep 10, 2026
- 9
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as Thane Wettig. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- James A. Schoeneck - $119K in KYNB purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Thane Wettig?
Thane Wettig is a corporate insider, tracked as CEO, Director of KYNTRA BIO, INC. (KYNB). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Thane Wettig submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Thane Wettig been buying or selling stock?
Recorded transactions: 4 open-market purchases ($73K) and 0 open-market sales across all tracked filings.
